S100A4 and histiocytic sarcoma: Therefore, we suggest that the serum level of S100A4 may serve as a biomarker to predict and monitor inflammatory processes and fibrosis in individuals with HS; in particular, S100A4 may facilitate differentiation between stage I and the more advanced stages according to Hurley classification.